tion. In such cases there is not usually any detectable immunological damage within the kidney and the influence of vasoactive substances on the microcirculation may be very important in the pathogenesis of the renal lesions. In the second group of disorders the kidney is the major site of disease and localized thrombosis and fibrin deposition is superimposed on demonstrable immunological or other endothelial damage.
Renal lesions caused by systemic intravascular coagulation
Whatever the cause of disseminated intravascular coagulation, the kidney is an important target organ [21. Thrombosis itself will cause damage [3] , and although some lesions are reversible others are permanent. The nature and duration of the stimulus which causes coagulation, and the intensity and effectiveness of the local and generalized fibrinolytic activity which it provokes, may both influence the resulting renal damage.
Glomerular damage resulting from thrombosis. Induction of intravascular coagulation produces an almost immediate reaction in mesangial cells characterized by swelling and an increase in vacuoles, organelles, free ribosomes and mitochondria [3] . These changes are accompanied by phagocytosis of fibrin and secretion of basement membranelike material [3] . Within hours a marked increase in local fibrinolytic activity (plasminogen activator) is present in glomeruli [4] and cellular proliferation and other changes appear within days [3] .
The glomerular lesions which result from intravascular coagulation cover the whole range of morphological reactions seen in glomerulonephritis in man except for that of extramembranous glomerulonephritis [3, 5] . Platelets and fibrin may be seen in the lumen and endothelial cells show © 1972, by the International Society of Nephrology.
183 similar changes to those in mesangial cells. Subendotheiial or intramembranous deposits may be translucent or consist of dense fibrinoid material which probably represents fibrin degradation products [3, 6] . Marked cellular proliferation associated with increased deposition of mesangial matrix may closely mimic the appearance of mesangialproliferative glomerulonephritis [7] . When these changes are accompanied by layers of basement membrane-like material within glomerular capillaries and by interposed mesangial cell processes the lesion resembles mesangiocapillary (membranoproliferative) glomerulonephritis [8] .
Continuing deposition of basement membrane-like material can cause complete occlusion of glomerular capillaries and hyalinization of glomeruli [3, 5, 8] .
The importance of vasoactive phenomena within the microcirculation. Vasomotor activity undoubtedly plays an important part in determining the extent and severity of the effects of intravascular coagulation on the kidney. Vasomotor factors may play a direct causal role in some situations. The evidence relating to participation of catecholamines is best defined in relation to two conditions, renal cortical ischaemia which accompanies hemorrhagic shock and the generalized Sanarelli-Schwartzman reaction. In both the renal abnormalities can be prevented by blocking adrenergic receptors [9, 10] . Although these two conditions may be regarded as distinct their pathogenetic mechanisms are probably very similar. Catecholamine levels are known to be very high in endotoxic and hemorrhagic shock [11, 12] and probably cause the intense vasoconstriction and decrease in blood flow in the outer renal cortex in such states which can be abolished by blocking adrenergic receptors [9] . The Sanarelli-Schwartzman phenomenon which results from two injections of bacterial endotoxin (or from a single injection in a pregnant rabbit) can also be blocked by blocking x-receptors [10] . It induces severe hypotension as well as disseminated intravascular coagulation and resembles a severe form of endotoxic shock.
The clinical counterpart of experimental shock is acute renal failure associated with acute tubular necrosis. There is now ample evidence of fibrin deposition in glomeruli and intravascular coagulation in acute tubular necrosis [13] [14] [15] [16] [17] [18] . Catecholamine infusion will itself produce shock and intravascular coagulation [19] , which suggests that excessive catecholamine secretion may cause intravascular coagulation in acute renal failure associated with acute tubular necrosis.
The clinical counterpart of the Sanarelli-Schwartzman phenomenon is renal cortical necrosis and this is particularly liable to occur in late pregnancy [20] . The experimental form can be prevented by adrenergic blockade [10] suggesting that catecholamines play an important part in its pathogenesis.
Heparin will counteract the renal effects of both catecholamine-induced shock [19] There is also considerable evidence that the renin-angiotensin system may play a part in the pathogenesis of acute renal failure. Plasma renin activity is markedly elevated in clinical and experimental acute renal failure, including those forms which have been attributed to a toxic effect [28] [29] [30] [31] . As both renal vasoconstriction and intravascular coagulation may also occur in nephrotoxic renal failure (Friedman and Kincaid-Smith, unpublished observations), this may also prove to have an ischemic basis. Whether the high renin levels play a primary or secondary role in renal ischemia associated with acute tubular necrosis is still a matter of debate [30] . Angiotensin infusion will cause acute tubular necrosis [31] , and as both ac-blocking agents [9] and passive immunization against angiotensin-Il [32] afford some degree of protection against acute renal failure, catcholamines and angiotensin probably both play a part in the pathogenesis of acute renal failure. Recent work suggests that sympatho-adrenergic mechanisms may cause the cortical hypoperfusion of hemorrhagic shock but that the renin-angiotensin system plays a permissive role in its pathogenesis [30] .
Malignant hypertension. Vasoactive mechanisms within the microcirculation may also initiate intravascular coagulation in malignant hypertension. Pregnancy and pre-eclamptic toxemia. During pregnancy the kidney seems to be particularly susceptible to damage by mechanisms involving intravascular coagulation.
Pregnant animals will develop a generalized SanarelliSchwartzman reaction with only a single injection of bacterial endotoxin and pregnant women are particularly likely to develop renal failure as a result of infective or hemorrhagic complications. Pre-eclamptic toxemia is the most common complication of pregnancy and it probably represents a chronic state of intravascular coagulation [2, 40] . There is widespread fibrin deposition in renal vessels and glomeruli [41] without demonstrable immunological damage and fibrin degradation products are elevated. In spite of the extent of subendothelial fibrin deposits in severe cases, the clinical features of pre-eclamptic toxemia usually reverse rapidly when the uterus is emptied. Although it has been assumed that morphological lesions are also reversible prospective biopsy studies show that they may persist for months [42] . Six months after pregnancy glomerular lesions may closely resemble mesangiocapillary (membrano-proliferative) glomerulonephritis [42] except that proliferation is slight or absent, but biopsies may show continuing resolution over a further period of a year or more. Arterial lesions closely resembling those of severe hypertension and perhaps due to organization of thrombi within the renal vessels may develop in pre-eclamptic toxemia when the blood pressure is not elevated and may persist indefinitely [42] .
Thrombotic microangiopathy including post-partum renal failure and the hemolytic-uremic syndrome. In post-partum renal failure disseminated intravascular coagulation is more intense and vessel lesions are similar to, but more marked than, the lesions seen in pre-eclamptic toxemia. Cases of early post-partum renal failure form an intermediate group, often having marked evidence of intravascular coagulation but a better prognosis than those who present later [42] . Severe cases are usually rapidly fatal and resemble other cases of thrombotic microangiopathy in adults [43] except for the predominant renal manifestations. The kidney is the major site of damage which results from the intravascular coagulation, and death in renal failure is usual unless this can be reversed by heparin therapy [44] [45] [46] . On the one hand thrombotic microangiopathy merges into the more chronic disorder of thrombotic thrombocytopenic purpura in which there is relatively more evidence of vascular involvement in other organs [43, 47] , and on the other hand thrombotic microangiopathy in adults merges into the hemolytic-uremic syndrome which is characteristically a disease of young children. The latter term should probably be confined to cases of the type which Gasser described [48] .
Apart from the greater frequency of vessel lesions in organs outside the kidney, the pathological features of thrombotic microangiopathy in adults are very similar to those in the hemolytic-uremic syndrome in children. The vessel lesions may precede hypertension and then lead to a fulminating form of hypertension particularly when thrombotic microangiopathy follows pregnancy [46, 49] . Translucent subendothelial deposits, which are an important ultrastructural finding in the thrombotic microangiopathies and in other conditions where active fibrin deposition and lysis occur, are discussed in a broader context below. Vasoactive changes in the microcirculation may also be important in this group of disorders. Some consider that they represent the clinical counterpart of the experimental Sanarelli-Schwartzman phenomenon [50] which can be prevented by a-blocking agents.
The etiology of this group of disorders is unknown but it has been postulated that they may represent an abnormal immunological response to an antigen [51] . The antigen could be of viral origin in the hemolytic-uremic syndrome in childhood, of bacterial or viral origin in the spontaneous cases of thrombotic microangiopathy, and perhaps related to the products of conception in post-partum renal failure. Modern immunological methods have failed to show any antigen or antibody within the kidney in patients with thrombothic microangiopathy or the hemolytic-uremic syndrome. However, it is of interest that the translucent subendothelial zones in lesions induced by virus infection in mice [52] so closely resemble those in the hemolyticuremic syndrome and experimental thrombosis.
Lesions in which thrombosis is probably secondary to immunological or other damage in vessels or glomeruli
In the second group of disorders in which thrombosis participates in the formation of renal lesions, there is usually evidence of underlying immunological or other damage within the kidney.
Renal lesions in animals. Two naturally occurring diseases in animals, namely, glomerulonephritis in NZB mice [53] where the antigen is DNA [54, 55] and the Aleutian disease of the mink in which the antigen is probably of viral origin, show prominent fibrin deposition within glomeruli and vessels. Associated coagulation disorders in the mink suggest a prolonged state of intravascular coagulation [57] . In NZB mice the importance of coagulation as an intermediary mechanism is shown by massive fibrin deposition and resulting rapid progress of the lesions following injection of DNA when anti-DNA antibodies are circulating [54] .
The participation of local coagulation in renal vessels and glomeruli in other forms of experimental glomerulonephritis has been well documented and reviewed by Vassalli and McCluskey [5, 58] .
Fibrin deposition has also been shown to be a universal and important pathogenetic mechanism in long-surviving allografts in rats. Here the trigger mechanism initiating fibrin deposition does not seem to be immunoglobulin deposition [65] .
Renal lesions in man: the nature of the underlying damage.
In properdin which is present in all cases of chronic mesangiocapillary (membranoproliferative) glomerulonephritis [59] . Deposits of fibrin or fibrinoid material and fibrin degradation products in the serum. Fibrinoid material is commonly deposited within glomeruli and it probably represents a fibrin monomer or some other fibrin breakdown product [6] . It resembles the granular fibrinoid material that is found after the infusion of thromboplastin [3] and it has the appearance of fibrin that is precipitated in the presence of degradation products in vitro [60] . It shows positive staining by immunofluorescent techniques [5] .
In a group of patients with idiopathic and specific forms of glomerulonephritis we found a positive correlation between the activity of glomerular lesions and the level of fibrin degradation products inthe serum [61, 621. Among 128 patients with idiopathic glomerulonephritis, only 12% of those with inactive lesions showed elevated fibrin degradation products in the serum. Whereas in diffuse mesangiocapillary (membranoproliferative) glomerulonephritis 51.6% had elevated fibrin degradation products, and this figure was even higher (70%) in patients with active lesions associated with fibrin and crescents in glomeruli [62] , these findings have been confirmed [63] .
Levels of fibrin degradation products correlated well with fibrin on immunofluorescent studies and electron microscopy, and also with clinical features suggesting active disease such as heavy proteinuria, renal functional deterioration and haematuria [61, 62] .
The level of fibrin degradation products in the serum correlates well with episodes of rejection in renal allografts [62, 64] . Fibrin is a prominent feature in allografts both in acute rejection and in long-standing allografts [38, 39] .
Biopsies at the time of grafting and repeatedly thereafter have permitted us to study the pathogenesis of the vascular and glomerular lesions in allografts. Organization of the products of coagulation seems to play an important part in acute and chronic allograft rejection [8, 38, 39, 65] . In long-standing allografts, the lesions of rejection may closely resemble those of chronic mesangiocapillary glomerulonephritis in patients whose original disease was not glomerulonephritis (39, and unpublished observations of the author).
Merrill has reviewed the possible factors contributing to this appearance [65] . The same changes develop in longstanding allografts in rats [65] , suggesting that they are related perhaps more closely to the organization of fibrin (which is a universal and prominent feature in such kidneys) than to glomerulonephritis arising de novo in the transplant. Fibrin deposition does not seem to depend upon immunoglobulin deposition [65] .
Translucent subendothelial deposits may provide an important marker of active deposition and lysis of fibrin in glomeruli [8, 66] . Habib et a! (67] described these lesions in the hemolytic-uremic syndrome in childhood and others found similar changes in adults [68] . These translucent zones are present in a wide variety of different disorders in which the common factor seems to be active deposition and lysis of fibrin within glomerular capillaries. They are prominent and widespread in the thrombotic microangiopathies but are also found in acute allograft rejection, active proliferative glomerulonephritis, pre-eclamptic toxemia [8, 39, 42, 66] and in acute tubular necrosis [69] . Patients in whom this change is pronounced often have a poor prognosis; however, if resolution does occur, collagen fibres within the capillary wall may be prominent in the healing stages [8, 39, 66] .
Treatment with antithrombotic and anticoagulant agents
The most important aspect of the participation of coagulation in the etiology of renal failure and the pathogenesis of renal lesions is the possible application of this knowledge to treatment.
Animal experiments. In experimental nephritis where treatment can be started before the lesions develop, the effects of anticoagulants have been dramatic. Not only do warfarin or heparin in adequate doses prevent deposition of fibrin or fibrinoid material, but they prevent glomerular sclerosis and crescent formation and progressive obliteration of glomeruli despite persisting immunoglobulin deposition and proteinuria [5, 58, 70] . Fibrinolytic agents have been even more effective than heparin in mice [71] . Likewise in the highly fatal form of "lupus" nephritis in NZB mice, Lambert [54] demonstrated marked alleviation of the histological lesions as well as significant prolongation of survival in mice treated with a daily injection of heparin.
In relation to the systemic forms of intravascular coagulation discussed above, both heparin [21] and warfarin [72] will prevent the Sanarelli-Schwartzman reaction. The importance of vasoactive factors in the pathogenesis of lesions and the possible role of platelets in causing and perpetuating vascular spasm means that both x-blocking agents and anti-thrombotic agents may increase the effectiveness of anticoagulant treatment.
Results There are several different groups of patients in which anticoagulants have been used alone or in combination with antithrombotic agents. In severe acute renal failure associated with diffuse glomerular or vascular lesions in adults, the reported prognosis without treatment or with steroids has been very poor [76] . As this clinical setting seems to provide one of the major indications for heparin therapy, and as the results of such treatment have usually been much better than previous therapeutic experience in this rapidly fatal group, we have been reluctant to set up prospective controlled studies in such patients [76] . Such studies can best be carried out by those who doubt the value of heparin therapy. Any one unit sees only an occasional patient with severe acute renal failure due to diffuse glomerular or vascular lesions; thus, a multi-center study with all of its incumbent disadvantages and difficulties would be necessary. Animal experiments and the rapid destruction of glomeruli which may occur in such patients indicate that early treatment is important and provision for this should be included in any controlled study that may be initiated.
An individual patient may show repeated response to heparin and subsequent deterioration when heparin is withdrawn; thus, such patients may act is their own control [76, 78] . Although this establishes that heparin is of benefit in improving renal function in individual patients, it does not provide an answer for the whole group of patients.
Another condition in which an acute onset is associated with widespread fibrin deposition is that of pre-eclamptic toxemia [40, 41] . The indication for heparin in such patients is to enable the pregnancy to continue and to permit survival of the baby. In severe pre-eclamptic toxemia which develops early in the third trimester, fetal loss is almost invariable. Heparin has been used in such cases with apparent success [80] .
In acute allograft rejection infusion of heparin has produced an improvement in renal function and renal blood flow and these have deteriorated again after the withdrawal of heparin [81, 821. In the gradual rejection which occurs in many cadaveric renal allografts, early results of treatment have [39, 87] encouraged us to set up a long-term prospective controlled trial of treatment which is still in progress and may still need to be continued for several years. It is possible that histological changes in serial biopsy specimens may show significant differences before clinical differences are apparent.
The most difficult group of all in which to assess any benefit from anticoagulant treatment is that of progressive chronic glomerulonephritis. In recent years general agreement has been reached about the classification of glomerulonephritis on a morphological basis. It has also been possible to better define the natural history of various forms of glomerulonephritis [88] . In many different forms of progressive glomerulonephritis the five year survival is reasonably good but 10 year survival is very poor. Prospective controlled trials in such patients would therefore need to be continued for five years or longer before one could expect to see significant alterations in survival as a result of treatment.
The only groups in which an answer might be obtained from shorter treatment periods are those in whom the prognosis is known to be grave. This has been so in adults with the nephrotic syndrome, hypertension and poor renal function with mesangiocapillary (membranoproliferative) glomerulonephritis [89] [90] [91] . A retrospective analysis of such patients presenting to this unit showed a highly significant (P<0.001) prolongation of survival in 16 patients treated for periods of 4 to 44 months with combined anticoagulants, dipyridamole and cyclophosphamide as compared with a similar group of 13 patients who were not treated in this way [92] . Renal function improved in 10 of 16 treated patients and five patients showed disappearance of proteinuria and microscopic haematuria and loss of the characteristic double contour appearance in glomerular capillaries [92] . Cade et al [85] have reported similar findings in a group of patients with chronic proliferative glomerulonephritis treated with long-term heparin. Michielsen and his group [93] [94] [95] and others [96] have reported a fall in fibrin degradation products and improvement in histological lesions in chronic proliferative glomerulonephritis with indomethacin. The abnormalities reappeared after withdrawal of indomethacin. Whether this effect is related to the antithrombotic action of indomethacin or to its antiinflammatory properties is not certain. The complicated interrelations between the inflammatory response and mechanisms of coagulation have recently been reviewed by McKay [97] . Heparin and antithrombotic agents such as dipyridamole and prostaglandin E will prevent inflammatory responses such as the Arthus reaction [97] . Inflammation in such conditions as gouty arthropathy depends upon activation of the Hagemann factor by urate crystals [98] , and inflammatory mechanisms at present poorly understood could play an important role in glomerulonephritis.
The role of complement in glomerulonephritis is also under close scrutiny. Complement plays a significant role in both immune and non-immune inflammation [99] and it has been suggested that complement may cause glomerular injury through mechanisms unrelated to the antigenantibody reactions [59] . The chemotactic effects of complement may lead to damage of the basement membrane by granulocytes and this in turn could lead to intravascular coagulation.
Whatever triggers intravascular coagulation in glomerulonephritis there is little doubt that coagulation participates in progressive damage. 
